Skip to main content

Table 4 Sensitivity to change: PPSM-Global by Study Treatment Arms at 2 Years

From: The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms

  

PPSM Questionnaire – PPSM-Global

 
  

Visit 2

(Baseline)

Visit 10

(2 Years)

Change:

Visit 2 to Visit 10

Effect Size

Treatment Arm

N

Mean

(SD)

Mean

(SD)

Mean

(SD)

 

0.5 mg dutasteride + 0.4 mg tamsulosin

158

25.55

(6.61)

17.76

(6.88)

-7.79

(7.21)

-1.17

0.5 mg dutasteride + placebo

190

25.40

(5.20)

20.32

(7.57)

-5.07

(8.08)

-0.97

0.4 mg tamsulosin + placebo

161

25.66

(6.09)

20.47

(7.55)

-5.19

(7.88)

-0.85

  1. Notes: Sample for separate visit scores includes everyone that has a PPSMQ Total Score (excl. pain) at both time points.
  2. Effect size: Mean change score (visit 2 to visit 10) divided by standard deviation of visit 2 score